Technology solutions for smarter clinical trials: Inventus
Inventus provides complete support exclusively for clinical trials. It is the only company to create purpose-built mobile devices, supported through global eSIM connectivity and industry-leading Mobile Device Management.
In an exclusive video interview, Steve Sanghera – CEO and co-founder of Inventus – sat down with pharmaphorum web editor Nicole Raleigh to discuss Inventus’ journey and the finer details of the company’s continuing central focus on ‘Patient, Site, Sponsor’.
The conversation touches upon the importance of pharma partnerships and the UK government’s clear commitment to prioritising reducing the average set-up time for commercial clinical trials, as well as Inventus’ Mobile Device Management solutions and the importance of tech solutions for smart clinical trials, today and in the future.
Watch the full interview here for Sanghera’s insights on Inventus’ work and providing solutions for patients, sites, and sponsors in UK clinical trials.
About the interviewee
Steve Sanghera is CEO and co-founder of Inventus. His extensive career spans over 20 years in mobile technology and financial solutions, including several senior roles with companies including Caudwell Group and Ikon Office Solutions. Sanghera also spent two years in an advisory role for the New York Stock Exchange focusing on the global mobile telecommunications industry. Over the last ten years, he has taken his previous learnings and channelled them into entrepreneurial activities, striving for a positive impact and creating change for the better.
About Inventus
Inventus is the world’s only company dedicated to creating bespoke technology solutions designed exclusively for clinical trials. As a global technology solutions leader, Inventus is pioneering the delivery of smarter, more efficient trials while always thinking about the patient and site experience. Working in partnership with the world’s largest pharmaceutical companies, eCOA partners, technology vendors, and the wider DCT and DHT ecosystem, Inventus’ technology solutions provide participants with confidence that their data is secure and that their experience from start to finish will be seamless and efficient. Over the last six years, Inventus has deployed 550,000 devices which have been used in more than 1,000 clinical trials across a multitude of therapeutic areas and countries, with support for up to 586 languages. This means anyone, anywhere in the world, can use its solutions with ease. Inventus is at the forefront in delivering preventative health technology solutions while driving clinical trials through connected technologies and fully sustainable device programmes that ensure zero waste.
